At the time of writing, MBX Biosciences Inc [MBX] stock is trading at $7.41, up 18.18%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MBX shares have gain 22.68% over the last week, with a monthly amount drifted -14.14%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MBX Biosciences Inc [NASDAQ: MBX] stock has seen the most recent analyst activity on April 10, 2025, when Citizens JMP initiated its Mkt Outperform rating and assigned the stock a price target of $38. Previously, Stifel started tracking the stock with Buy rating on October 08, 2024, and set its price target to $40. On October 08, 2024, JP Morgan initiated with a Overweight rating and assigned a price target of $30 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $35 on October 08, 2024. Guggenheim initiated its recommendation with a Buy and recommended $44 as its price target on October 08, 2024.
For the past year, the stock price of MBX Biosciences Inc fluctuated between $4.81 and $27.50. Currently, Wall Street analysts expect the stock to reach $44 within the next 12 months. MBX Biosciences Inc [NASDAQ: MBX] shares were valued at $7.41 at the most recent close of the market. An investor can expect a potential return of 493.79% based on the average MBX price forecast.
Analyzing the MBX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.48 and Total Capital is -0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.56 points at the first support level, and at 5.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.04, and for the 2nd resistance point, it is at 8.68.
Ratios To Look Out For
It is important to note that MBX Biosciences Inc [NASDAQ:MBX] has a current ratio of 24.19. Also, the Quick Ratio is 24.19, while the Cash Ratio stands at 4.47.
Transactions by insiders
Recent insider trading involved Pescovitz Ora H., Director, that happened on Apr 08 ’25 when 7693.0 shares were purchased. Director, GORDON CARL L completed a deal on Feb 18 ’25 to buy 0.14 million shares. Meanwhile, Director GORDON CARL L bought 47502.0 shares on Feb 14 ’25.
